Boston Scientific initially developed the concept for the Bolt IVL system, which is engineered to fracture calcium using ...

Boston Scientific stock popped Wednesday after the medtech giant agreed to full acquire Bolt Medical for up to $900 million.

Boston Scientific Corporation BSX recently entered into a definitive agreement to acquire Bolt Medical, Inc. — an ...

Boston Scientific (BSX) announced on Wednesday the acquisition of the ~74% stake in Bolt Medical that the medical devices ...

Acquisition Strengthens Boston Scientific's Position in Minimally Invasive Treatment for Coronary Artery Disease ...

Boston Scientific (NYSE: BSX) announced today that it agreed to acquire intravascular lithotripsy (IVL) platform developer ...

JPMorgan keeps an Overweight rating on Boston Scientific (BSX) with a $110 price target after the company announced an agreement to acquire the ...

Boston Scientific (BSX) announced it has entered into a definitive agreement to acquire Bolt Medical, the developer of an intravascular ...

Boston Scientific is diving into the field of intravascular lithotripsy, with a $664 million deal to pick up Bolt Medical and ...

The deal for Bolt, developer of an intravascular lithotripsy system to treat coronary and peripheral artery disease, ...

Boston Scientific to acquire Bolt Medical for $600 million upfront plus milestones. Bolt's IVL platform addresses coronary ...

Boston Scientific stock popped Wednesday after the medtech giant agreed to full acquire Bolt Medical for up to $900 million.